Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.8 HKD | -1.26% | +5.88% | +67.93% |
10:01am | Sichuan Kelun-Biotech Directors Approve Full Circulation of H-Shares | MT |
Jun. 18 | Hong Kong Shares Fall on Weak Economic Data, Trade Tensions; Wuhan Youji Surges 27% in Trading Debut | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.93% | 5B | |
+15.38% | 122B | |
+19.68% | 113B | |
+6.67% | 22.84B | |
-18.87% | 20.72B | |
-16.10% | 16.51B | |
-12.48% | 16.39B | |
-43.53% | 15.83B | |
+1.86% | 13.49B | |
+76.29% | 11.67B |
- Stock Market
- Equities
- 6990 Stock
- News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Sichuan Kelun-biotech Biopharmaceutical to Present Its Cancer Drug Phase 3 Study Results at ASCO